nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ABCG2—Topotecan—cervical cancer	0.515	0.634	CbGbCtD
Vismodegib—ABCB1—Topotecan—cervical cancer	0.186	0.229	CbGbCtD
Vismodegib—CYP3A4—Topotecan—cervical cancer	0.111	0.137	CbGbCtD
Vismodegib—SHH—epithelium—cervical cancer	0.0104	0.0859	CbGeAlD
Vismodegib—SHH—renal system—cervical cancer	0.00965	0.0796	CbGeAlD
Vismodegib—SHH—endometrium—cervical cancer	0.00933	0.077	CbGeAlD
Vismodegib—SHH—female reproductive system—cervical cancer	0.00773	0.0638	CbGeAlD
Vismodegib—SMO—uterine cervix—cervical cancer	0.00722	0.0595	CbGeAlD
Vismodegib—SMO—endometrium—cervical cancer	0.00653	0.0538	CbGeAlD
Vismodegib—SMO—mammalian vulva—cervical cancer	0.00631	0.0521	CbGeAlD
Vismodegib—SMO—uterus—cervical cancer	0.00601	0.0496	CbGeAlD
Vismodegib—SHH—Differentiation Pathway—WNT2—cervical cancer	0.00567	0.0842	CbGpPWpGaD
Vismodegib—SMO—female reproductive system—cervical cancer	0.00541	0.0446	CbGeAlD
Vismodegib—SMO—female gonad—cervical cancer	0.00492	0.0406	CbGeAlD
Vismodegib—SMO—vagina—cervical cancer	0.00489	0.0403	CbGeAlD
Vismodegib—SHH—Differentiation Pathway—WNT5A—cervical cancer	0.0043	0.0638	CbGpPWpGaD
Vismodegib—SHH—Class B/2 (Secretin family receptors)—WNT2—cervical cancer	0.00353	0.0523	CbGpPWpGaD
Vismodegib—SMO—Class B/2 (Secretin family receptors)—WNT2—cervical cancer	0.00334	0.0496	CbGpPWpGaD
Vismodegib—SMO—lymph node—cervical cancer	0.00316	0.0261	CbGeAlD
Vismodegib—ORM1—endometrium—cervical cancer	0.00285	0.0235	CbGeAlD
Vismodegib—SHH—Class B/2 (Secretin family receptors)—WNT5A—cervical cancer	0.00267	0.0397	CbGpPWpGaD
Vismodegib—SMO—Class B/2 (Secretin family receptors)—WNT5A—cervical cancer	0.00253	0.0376	CbGpPWpGaD
Vismodegib—ORM1—female reproductive system—cervical cancer	0.00236	0.0195	CbGeAlD
Vismodegib—SHH—Heart Development—NOTCH1—cervical cancer	0.002	0.0297	CbGpPWpGaD
Vismodegib—ABCG2—uterine cervix—cervical cancer	0.00189	0.0156	CbGeAlD
Vismodegib—SHH—Differentiation Pathway—NOTCH1—cervical cancer	0.00187	0.0277	CbGpPWpGaD
Vismodegib—CYP2C8—renal system—cervical cancer	0.00182	0.015	CbGeAlD
Vismodegib—ABCG2—decidua—cervical cancer	0.0018	0.0149	CbGeAlD
Vismodegib—CYP2C8—endometrium—cervical cancer	0.00176	0.0145	CbGeAlD
Vismodegib—ABCG2—endometrium—cervical cancer	0.00171	0.0141	CbGeAlD
Vismodegib—ABCG2—mammalian vulva—cervical cancer	0.00165	0.0136	CbGeAlD
Vismodegib—SHH—Dopaminergic Neurogenesis—STAT3—cervical cancer	0.00158	0.0234	CbGpPWpGaD
Vismodegib—ABCG2—uterus—cervical cancer	0.00157	0.013	CbGeAlD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00151	0.0224	CbGpPWpGaD
Vismodegib—CYP2C19—vagina—cervical cancer	0.00151	0.0124	CbGeAlD
Vismodegib—CYP2C8—female reproductive system—cervical cancer	0.00146	0.012	CbGeAlD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00143	0.0212	CbGpPWpGaD
Vismodegib—ORM1—lymph node—cervical cancer	0.00138	0.0114	CbGeAlD
Vismodegib—SHH—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—cervical cancer	0.00138	0.0205	CbGpPWpGaD
Vismodegib—SHH—Heart Development—CTNNB1—cervical cancer	0.00133	0.0197	CbGpPWpGaD
Vismodegib—CYP2C8—vagina—cervical cancer	0.00132	0.0109	CbGeAlD
Vismodegib—SMO—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—cervical cancer	0.00131	0.0194	CbGpPWpGaD
Vismodegib—CYP2C9—female reproductive system—cervical cancer	0.00129	0.0107	CbGeAlD
Vismodegib—ABCG2—female gonad—cervical cancer	0.00129	0.0106	CbGeAlD
Vismodegib—ABCG2—vagina—cervical cancer	0.00128	0.0106	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—TAAR6—cervical cancer	0.00123	0.0183	CbGpPWpGaD
Vismodegib—CYP3A4—renal system—cervical cancer	0.00123	0.0102	CbGeAlD
Vismodegib—ALB—lymph node—cervical cancer	0.00121	0.01	CbGeAlD
Vismodegib—SMO—GPCR ligand binding—TAAR6—cervical cancer	0.00117	0.0174	CbGpPWpGaD
Vismodegib—SHH—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—cervical cancer	0.00109	0.0162	CbGpPWpGaD
Vismodegib—SMO—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—cervical cancer	0.00104	0.0154	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000998	0.0148	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000988	0.0147	CbGpPWpGaD
Vismodegib—CYP3A4—female reproductive system—cervical cancer	0.000986	0.00814	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—WNT2—cervical cancer	0.000964	0.0143	CbGpPWpGaD
Vismodegib—ABCB1—epithelium—cervical cancer	0.00094	0.00775	CbGeAlD
Vismodegib—ABCB1—uterine cervix—cervical cancer	0.000932	0.00769	CbGeAlD
Vismodegib—SMO—GPCR ligand binding—WNT2—cervical cancer	0.000914	0.0136	CbGpPWpGaD
Vismodegib—ABCB1—decidua—cervical cancer	0.000888	0.00732	CbGeAlD
Vismodegib—ABCB1—renal system—cervical cancer	0.000872	0.00719	CbGeAlD
Vismodegib—ABCB1—endometrium—cervical cancer	0.000843	0.00695	CbGeAlD
Vismodegib—ABCG2—lymph node—cervical cancer	0.000828	0.00683	CbGeAlD
Vismodegib—ABCB1—mammalian vulva—cervical cancer	0.000815	0.00673	CbGeAlD
Vismodegib—ABCB1—uterus—cervical cancer	0.000777	0.00641	CbGeAlD
Vismodegib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000772	0.0115	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—WNT5A—cervical cancer	0.000731	0.0108	CbGpPWpGaD
Vismodegib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000721	0.0107	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000698	0.0104	CbGpPWpGaD
Vismodegib—ABCB1—female reproductive system—cervical cancer	0.000698	0.00576	CbGeAlD
Vismodegib—SMO—GPCR ligand binding—WNT5A—cervical cancer	0.000693	0.0103	CbGpPWpGaD
Vismodegib—ABCB1—female gonad—cervical cancer	0.000635	0.00524	CbGeAlD
Vismodegib—SHH—Signaling by GPCR—TAAR6—cervical cancer	0.000634	0.00941	CbGpPWpGaD
Vismodegib—ABCB1—vagina—cervical cancer	0.000631	0.00521	CbGeAlD
Vismodegib—SMO—Signaling by GPCR—TAAR6—cervical cancer	0.000601	0.00892	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000564	0.00837	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000534	0.00793	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000534	0.00793	CbGpPWpGaD
Vismodegib—SHH—Ectoderm Differentiation—CTNNB1—cervical cancer	0.000533	0.00791	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—WNT2—cervical cancer	0.000495	0.00734	CbGpPWpGaD
Vismodegib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000476	0.00706	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.000475	0.00705	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—WNT2—cervical cancer	0.000469	0.00696	CbGpPWpGaD
Vismodegib—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000458	0.0068	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—AKAP13—cervical cancer	0.000434	0.00645	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000426	0.00633	CbGpPWpGaD
Vismodegib—SHH—Disease—WNT2—cervical cancer	0.000417	0.00619	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000415	0.00616	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—AKAP13—cervical cancer	0.000412	0.00611	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000411	0.0061	CbGpPWpGaD
Vismodegib—ABCB1—lymph node—cervical cancer	0.000408	0.00337	CbGeAlD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000404	0.006	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.0004	0.00594	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00039	0.00578	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—WNT5A—cervical cancer	0.000375	0.00556	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TAAR6—cervical cancer	0.000374	0.00556	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—WNT5A—cervical cancer	0.000355	0.00528	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TAAR6—cervical cancer	0.000355	0.00527	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000326	0.00483	CbGpPWpGaD
Vismodegib—SHH—Disease—WNT5A—cervical cancer	0.000316	0.00469	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000309	0.00458	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.000304	0.00451	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—WNT2—cervical cancer	0.000292	0.00434	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	0.000288	0.00428	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—WNT2—cervical cancer	0.000277	0.00411	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000273	0.00406	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	0.000265	0.00394	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000259	0.00385	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AKAP13—cervical cancer	0.000257	0.00381	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—MTHFR—cervical cancer	0.000247	0.00367	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—GP6—cervical cancer	0.000245	0.00363	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SERPIND1—cervical cancer	0.000245	0.00363	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AKAP13—cervical cancer	0.000243	0.00361	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	0.000225	0.00334	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—WNT5A—cervical cancer	0.000221	0.00329	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000216	0.00321	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—GP5—cervical cancer	0.000214	0.00318	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—WNT5A—cervical cancer	0.00021	0.00312	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000197	0.00292	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000194	0.00288	CbGpPWpGaD
Vismodegib—SHH—Disease—HES1—cervical cancer	0.000182	0.0027	CbGpPWpGaD
Vismodegib—SHH—Disease—MTHFR—cervical cancer	0.00016	0.00237	CbGpPWpGaD
Vismodegib—SHH—Disease—TERT—cervical cancer	0.000159	0.00237	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NOTCH2—cervical cancer	0.000155	0.00231	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NOTCH2—cervical cancer	0.000147	0.00219	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CASP8—cervical cancer	0.000147	0.00218	CbGpPWpGaD
Vismodegib—SHH—Disease—FGFR3—cervical cancer	0.000146	0.00217	CbGpPWpGaD
Vismodegib—SHH—Disease—NOTCH1—cervical cancer	0.000137	0.00204	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HES1—cervical cancer	0.000127	0.00189	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HES1—cervical cancer	0.000121	0.00179	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TERT—cervical cancer	0.000112	0.00166	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CASP3—cervical cancer	0.000111	0.00165	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TERT—cervical cancer	0.000106	0.00157	CbGpPWpGaD
Vismodegib—SHH—Disease—MTOR—cervical cancer	0.000103	0.00153	CbGpPWpGaD
Vismodegib—SHH—Disease—CD4—cervical cancer	0.000103	0.00153	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—FGFR3—cervical cancer	0.000102	0.00152	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—FGFR3—cervical cancer	9.71e-05	0.00144	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NOTCH1—cervical cancer	9.62e-05	0.00143	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—cervical cancer	9.39e-05	0.00139	CbGpPWpGaD
Vismodegib—SHH—Disease—CTNNB1—cervical cancer	9.13e-05	0.00135	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NOTCH1—cervical cancer	9.12e-05	0.00135	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—EGFR—cervical cancer	8.57e-05	0.00127	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—EGFR—cervical cancer	8.13e-05	0.00121	CbGpPWpGaD
Vismodegib—SHH—Disease—STAT3—cervical cancer	7.96e-05	0.00118	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CA9—cervical cancer	7.85e-05	0.00117	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	7.25e-05	0.00108	CbGpPWpGaD
Vismodegib—SHH—Disease—EGFR—cervical cancer	7.23e-05	0.00107	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MTOR—cervical cancer	7.21e-05	0.00107	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MTOR—cervical cancer	6.83e-05	0.00101	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CASP3—cervical cancer	6.63e-05	0.000984	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CTNNB1—cervical cancer	6.39e-05	0.000949	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CASP3—cervical cancer	6.29e-05	0.000933	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CTNNB1—cervical cancer	6.06e-05	0.000899	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—STAT3—cervical cancer	5.57e-05	0.000827	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	5.49e-05	0.000814	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	5.29e-05	0.000785	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—STAT3—cervical cancer	5.28e-05	0.000784	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EGFR—cervical cancer	5.06e-05	0.000752	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CA9—cervical cancer	4.87e-05	0.000724	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CA9—cervical cancer	4.85e-05	0.000719	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EGFR—cervical cancer	4.8e-05	0.000713	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CA9—cervical cancer	4.35e-05	0.000646	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—cervical cancer	4.25e-05	0.000631	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CA9—cervical cancer	4.25e-05	0.00063	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	4.19e-05	0.000622	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—cervical cancer	4.03e-05	0.000598	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CA9—cervical cancer	3.97e-05	0.000589	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	3.52e-05	0.000522	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—MTHFR—cervical cancer	3.19e-05	0.000473	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA9—cervical cancer	2.62e-05	0.000388	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MTHFR—cervical cancer	1.98e-05	0.000294	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MTHFR—cervical cancer	1.97e-05	0.000292	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—cervical cancer	1.84e-05	0.000273	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MTHFR—cervical cancer	1.77e-05	0.000262	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MTHFR—cervical cancer	1.72e-05	0.000256	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MTHFR—cervical cancer	1.61e-05	0.000239	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTHFR—cervical cancer	1.06e-05	0.000158	CbGpPWpGaD
